canakinumab
novartis
['canakinumab']
interim reliance registry data of fmf patients treated with canakinumab shows efficacy and safety of long-term tx including w/ dose adjustments. abs 0138 #acr22 
Passionately curious rheumatologist, world traveler, wife, mother, sister, daughter, friend, dog lover. Believer in scientific method & evidence based medicine.